Triad Clinical Trials - NC Guilford, Greensboro 27410

Triad Clinical Trials entered the industry of Physicians Assistants in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 6213993, which describes it as a Physicians Assistants. For further clarification, the SIC classifies this business under the code 8049 and described it as a Physicians Assistants. The business provides service to the B2C market.

To acquire more information, please contact Mary Kureczka, Owner by calling (336) 235-0991 during business hours. You can also write to the business’ Single Location at 515 College Road # 15, Greensboro, North Carolina NC 27410. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Triad Clinical Trials
Representative: Mary Kureczka, Owner
Place of Business: 515 College Road # 15, Greensboro, NC 27410
Contact Number: (336) 235-0991
Type of Service: Physicians Assistants
SIC Number: 8049
NAICS Number: 6213993
Locality: Single Location
Market Type: B2C (Business to Consumer)
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Triad Clinical Trials is a company operating from Guilford, North Carolina providing professional Physicians Assistants and relevant B2C variables. It was founded in 0 and registered with the SIC code 8049 as Physicians Assistants, and with the NAICS code 6213993 as Physicians Assistants.

With a current employee count of 1 to 4, Triad Clinical Trials has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Mary Kureczka, Owner at (336) 235-0991 for related queries, or to locate its Single Location using the coordinates 36.084996,-79.890402.

The Single Location can also be found at the street address 515 College Road # 15 in Greensboro, North Carolina 27410 and can be engaged online through the company website at , the company Twitter , and Facebook page .